Immunocore Holdings Plc (IMCR)
30.98
-1.14
(-3.55%)
USD |
NASDAQ |
Oct 23, 16:00
31.07
+0.09
(+0.29%)
After-Hours: 20:00
Immunocore Holdings Net Income (Quarterly) : -0.8095M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8095M |
| March 31, 2026 | 12.95M |
| December 31, 2025 | -30.02M |
| September 30, 2025 | -0.1759M |
| June 30, 2025 | -10.43M |
| March 31, 2025 | 5.042M |
| December 31, 2024 | -23.55M |
| September 30, 2024 | 8.826M |
| June 30, 2024 | -11.63M |
| March 31, 2024 | -24.42M |
| December 31, 2023 | -19.90M |
| September 30, 2023 | 2.409M |
| Date | Value |
|---|---|
| June 30, 2023 | -17.07M |
| March 31, 2023 | -19.63M |
| December 31, 2022 | -29.56M |
| September 30, 2022 | 7.322M |
| June 30, 2022 | -7.678M |
| March 31, 2022 | -21.63M |
| December 31, 2021 | -53.09M |
| September 30, 2021 | -41.52M |
| June 30, 2021 | -46.10M |
| March 31, 2021 | -40.04M |
| December 31, 2020 | -24.93M |
| December 31, 2019 | -33.41M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Silence Therapeutics Plc | -12.27M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -4.134M |
| Mereo BioPharma Group Plc | -7.018M |
| Compass Pathways Plc | -254.25M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 116.14M |
| Total Expenses (Quarterly) | 116.95M |
| EPS Diluted (Quarterly) | -0.0159 |
| Enterprise Value | 1.150B |
| Gross Profit Margin (Quarterly) | 98.18% |
| Profit Margin (Quarterly) | -0.70% |
| Earnings Yield | -1.19% |
| Normalized Earnings Yield | -1.827 |